From Name:
From Email:
To Name:
To Email:

Optional Message:

Drug combination demonstrates proof of concept in controlling HCV

from Medscape Medical News

A four-week lead in the dosing of two oral small-molecule drugs was able to reduce the level of hepatitis C virus (HCV) RNA to undetectable levels in a small number of patients before either ribavirin or an interferon/RBV combination was added to the regimen. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063